Procaspase-3 Overexpression in Cancer: A Paradoxical Observation with Therapeutic Potential

Matthew W. Boudreau, Jessie Peh, Paul J. Hergenrother

Research output: Contribution to journalReview article

Abstract

Many anticancer strategies rely on the promotion of apoptosis in cancer cells as a means to shrink tumors. Crucial for apoptotic function are executioner caspases, most notably caspase-3, that proteolyze a variety of proteins, inducing cell death. Paradoxically, overexpression of procaspase-3 (PC-3), the low-activity zymogen precursor to caspase-3, has been reported in a variety of cancer types. Until recently, this counterintuitive overexpression of a pro-apoptotic protein in cancer has been puzzling. Recent studies suggest subapoptotic caspase-3 activity may promote oncogenic transformation, a possible explanation for the enigmatic overexpression of PC-3. Herein, the overexpression of PC-3 in cancer and its mechanistic basis is reviewed; collectively, the data suggest the potential for exploitation of PC-3 overexpression with PC-3 activators as a targeted anticancer strategy.

Original languageEnglish (US)
Pages (from-to)2335-2348
Number of pages14
JournalACS chemical biology
Volume14
Issue number11
DOIs
StatePublished - Nov 15 2019

Fingerprint

Caspase 3
Observation
Neoplasms
Therapeutics
Apoptosis Regulatory Proteins
Enzyme Precursors
Cell death
Caspases
Tumors
Cell Death
Cells
Apoptosis
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Cite this

Procaspase-3 Overexpression in Cancer : A Paradoxical Observation with Therapeutic Potential. / Boudreau, Matthew W.; Peh, Jessie; Hergenrother, Paul J.

In: ACS chemical biology, Vol. 14, No. 11, 15.11.2019, p. 2335-2348.

Research output: Contribution to journalReview article

@article{ed6bd3e85f3c440cbb87ad0afb11ec70,
title = "Procaspase-3 Overexpression in Cancer: A Paradoxical Observation with Therapeutic Potential",
abstract = "Many anticancer strategies rely on the promotion of apoptosis in cancer cells as a means to shrink tumors. Crucial for apoptotic function are executioner caspases, most notably caspase-3, that proteolyze a variety of proteins, inducing cell death. Paradoxically, overexpression of procaspase-3 (PC-3), the low-activity zymogen precursor to caspase-3, has been reported in a variety of cancer types. Until recently, this counterintuitive overexpression of a pro-apoptotic protein in cancer has been puzzling. Recent studies suggest subapoptotic caspase-3 activity may promote oncogenic transformation, a possible explanation for the enigmatic overexpression of PC-3. Herein, the overexpression of PC-3 in cancer and its mechanistic basis is reviewed; collectively, the data suggest the potential for exploitation of PC-3 overexpression with PC-3 activators as a targeted anticancer strategy.",
author = "Boudreau, {Matthew W.} and Jessie Peh and Hergenrother, {Paul J.}",
year = "2019",
month = "11",
day = "15",
doi = "10.1021/acschembio.9b00338",
language = "English (US)",
volume = "14",
pages = "2335--2348",
journal = "ACS Chemical Biology",
issn = "1554-8929",
publisher = "American Chemical Society",
number = "11",

}

TY - JOUR

T1 - Procaspase-3 Overexpression in Cancer

T2 - A Paradoxical Observation with Therapeutic Potential

AU - Boudreau, Matthew W.

AU - Peh, Jessie

AU - Hergenrother, Paul J.

PY - 2019/11/15

Y1 - 2019/11/15

N2 - Many anticancer strategies rely on the promotion of apoptosis in cancer cells as a means to shrink tumors. Crucial for apoptotic function are executioner caspases, most notably caspase-3, that proteolyze a variety of proteins, inducing cell death. Paradoxically, overexpression of procaspase-3 (PC-3), the low-activity zymogen precursor to caspase-3, has been reported in a variety of cancer types. Until recently, this counterintuitive overexpression of a pro-apoptotic protein in cancer has been puzzling. Recent studies suggest subapoptotic caspase-3 activity may promote oncogenic transformation, a possible explanation for the enigmatic overexpression of PC-3. Herein, the overexpression of PC-3 in cancer and its mechanistic basis is reviewed; collectively, the data suggest the potential for exploitation of PC-3 overexpression with PC-3 activators as a targeted anticancer strategy.

AB - Many anticancer strategies rely on the promotion of apoptosis in cancer cells as a means to shrink tumors. Crucial for apoptotic function are executioner caspases, most notably caspase-3, that proteolyze a variety of proteins, inducing cell death. Paradoxically, overexpression of procaspase-3 (PC-3), the low-activity zymogen precursor to caspase-3, has been reported in a variety of cancer types. Until recently, this counterintuitive overexpression of a pro-apoptotic protein in cancer has been puzzling. Recent studies suggest subapoptotic caspase-3 activity may promote oncogenic transformation, a possible explanation for the enigmatic overexpression of PC-3. Herein, the overexpression of PC-3 in cancer and its mechanistic basis is reviewed; collectively, the data suggest the potential for exploitation of PC-3 overexpression with PC-3 activators as a targeted anticancer strategy.

UR - http://www.scopus.com/inward/record.url?scp=85071522613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071522613&partnerID=8YFLogxK

U2 - 10.1021/acschembio.9b00338

DO - 10.1021/acschembio.9b00338

M3 - Review article

C2 - 31260254

AN - SCOPUS:85071522613

VL - 14

SP - 2335

EP - 2348

JO - ACS Chemical Biology

JF - ACS Chemical Biology

SN - 1554-8929

IS - 11

ER -